Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A cross-neutralizing antibody between HIV-1 and influenza virus

PLoS Pathogens(2021)10.1371/journal.ppat.1009407Source: DataRank Database

A cross-neutralizing antibody between HIV-1 and influenza virus is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.52)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yasunori Watanabe ORCID,Nicholas C. Wu ORCID,Julianna Han ORCID,Sonu Kumar ORCID,Tossapol Pholcharee ORCID

Live enrichment

PubMed:33750987 PMC:PMC8016226 OpenAlex:https://openalex.org/W3138091986

Academia Sinica

Grant: Academia Sinica Fellowship

National Institutes of Health

Grant: K99 AI139445

Bill and Melinda Gates Foundation

Grant: OPP1196345

Bill and Melinda Gates Foundation

Grant: OPP1170236

Bill and Melinda Gates Foundation

Grant: INV-004923

FWCI

4.52

Citation Percentile

1.0%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009407&type=printable

GOLDhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009407&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009407&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009407

journalhttps://doi.org/10.1371/journal.ppat.1009407

Fields of Study

Influenza Virus Research StudiesHIV Research and TreatmentRespiratory viral infections researchMedicineBiology

MeSH Terms

Broadly Neutralizing AntibodiesAntibodies, ViralCross ReactionsHumansInfluenza, HumanHIV-1HIV InfectionsHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H3N2 Subtype

Keywords

Hemagglutinin (influenza)GlycanEpitopeGlycosylationVirologyBiologyInfluenza A virusAntigenic driftVirusPopulationAntibodyGlycoproteinGenetics

Sustainable Development Goals

SDG 0: Good health and well-being

A cross-neutralizing antibody between HIV-1 and influenza virus

FAIR Checklist

Authors (15)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)